RELIANT PHARMACEUTICALS
Reliant Pharmaceuticals provides cardiovascular pharmaceutical products. It is engaged in the sale and marketing of these products. Its product portfolio includes Axid, a nizatidin; InnoPran XL and DynaCirc CR for the treatment of hypertension; Omacor to reduce high triglycerides; and Rythmol SR. It provides products for the treatment of elevated cholesterol and triglycerides, acid reflux disease, and prevention of coronary complications in patients with coronary heart disease. It distributes its products to physicians engaged in primary care, cardiovascular, and specialized medical areas. Reliant Pharmaceuticals was established in 1999, headquartered in Liberty Corner, New Jersey.
RELIANT PHARMACEUTICALS
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
1999-01-01
Address:
Bernardsville, New Jersey, United States
Country:
United States
Total Employee:
501+
Status:
Active
Total Funding:
275 M USD
Current Advisors List
Founder
Investors List
Pritzker/Vlock Family Office
Pritzker/Vlock Family Office investment in Series D - Reliant Pharmaceuticals
Bay City Capital
Bay City Capital investment in Series D - Reliant Pharmaceuticals
Invemed Catalyst Fund
Invemed Catalyst Fund investment in Series D - Reliant Pharmaceuticals
BayStar Capital
BayStar Capital investment in Series D - Reliant Pharmaceuticals
Bay City Capital
Bay City Capital investment in Series C - Reliant Pharmaceuticals
More informations about "Reliant Pharmaceuticals"
Reliant Pharmaceuticals - Wikipedia
Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 for $1.65B. [1] Co-founded by Joseph J. Krivulka. It was known for six major products, including Lovaza (Omega-3), Axid (H2 blocker), Dynacirc CR (calcium channel blocker), Antara …See details»
Reliant Pharmaceuticals - Crunchbase Company Profile …
Reliant Pharmaceuticals provides cardiovascular pharmaceutical products. It is engaged in the sale and marketing of these products. Its product portfolio …See details»
Reliant Pharmaceuticals
Reliant Pharmaceuticals, Inc. was a pharmaceutical company that specialized in the development, commercialization and marketing of prescription therapeutic products. Reliant marketed six …See details»
Reliant Pharmaceuticals - Ownership and Business Overview
Dec 19, 2007 Reliant Pharmaceuticals was founded in 1999. Life Science M&A Summary in 2007 Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2007 .See details»
Reliant Pharmaceuticals - PitchBook
Reliant Pharmaceuticals General Information Description. Developer of cardiovascular therapies. The company acquires and develops branded pharmaceutical products, as well as potential …See details»
GSK to Acquire Reliant Pharmaceuticals | Fierce Biotech
Nov 21, 2007 Reliant, a privately held specialty pharmaceutical company focused on cardiovascular therapies, recorded net sales of $341 million in the nine months ending …See details»
Organization | Reliant Pharmaceuticals
Reliant Pharmaceuticals Report issue. For profit Phase 4. Founded: Liberty Corner NJ United States ... Organization Overview. First Clinical Trial. 2006 NCT00454493. First Marketed Drug. …See details»
Reliant Pharmaceuticals - Funding, Financials, Valuation & Investors
Reliant Pharmaceuticals provides cardiovascular pharmaceutical products.See details»
Reliant Pharmaceuticals LLC - Drug pipelines, Patents, Clinical trials ...
Explore Reliant Pharmaceuticals LLC with its drug pipeline, therapeutic area, technology platform, 9 clinical trials, 5 news, and 1 literature.See details»
Reliant Pharmaceuticals, LLC Information
In addition, Reliant acquires rights to branded pharmaceutical products that typically have regulatory exclusivity or patent protection. Reliant also acquires rights to and develops product …See details»
Reliant Pharmaceuticals Inc - Company Profile and News
Company profile page for Reliant Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
How A Billionaire Clan Made Money In Biotech - Forbes
Mar 25, 2002 As Pritzker tells it, Reliant Chief Executive Joe Krivulka came to him with an idea for building a pharmaceutical company from scratch. Compared with most biotechnology …See details»
T P O – Reliant Pharmaceuticals - pritzkerorg.com
CHICAGO OFFICE 150 North Riverside Plaza Suite 3200 Chicago, IL 60606 312-873-4900 [email protected]See details»
Reliant Pharmaceuticals, Liberty Corner, NJ - 110 Allen Rd. - Zinc ...
According to our records, this business is located at 110 Allen Rd. in Liberty Corner (in Somerset County), New Jersey 07938, the location GPS coordinates are: 40.6501408 (latitude), …See details»
GlaxoSmithKline Completes Acquisition Of Reliant Pharmaceuticals
Dec 19, 2007 GlaxoSmithKline announced recently that it had completed the acquisition of Reliant Pharmaceuticals. This follows the US Federal Trade Commission's early termination of …See details»
Reliant Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Reliant Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and …See details»
Reliant Pharmaceuticals - DevelopmentAid
Reliant Pharmaceuticals — Supplier from Kenya, has experience with World Bank HQ, it`s involved in Health sector. Our website uses cookies to enable essential features and improve …See details»
Reliant Pharmaceuticals - Wikiwand
Reliant Pharmaceuticals, Inc. was a pharmaceutical company that specialized in the development, commercialization and marketing of prescription therapeutic products. Reliant marketed six …See details»
Reliant Pharmaceuticals - Products, Competitors, Financials, …
Iroko Pharmaceuticals Makes Strategic Additions to the Companys Board of Directors. Feb 18, 2014. NovaBay makes additions to board Iroko Pharmaceuticals, LLC, a global specialty …See details»
Glaxo to buy heart drug firm Reliant | Reuters
Nov 21, 2007 GlaxoSmithKline Plc <GSK.L> has agreed to buy privately held heart drug specialist Reliant Pharmaceuticals for $1.65 billion in cash, in a move to boost its flagging drug …See details»